User profiles for Richard EK Russell
Richard RussellRespiratory Medicine, Nuffield Dept of Medicine, University of Oxford Verified email at kcl.ac.uk Cited by 7047 |
Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive …
REK Russell, SV Culpitt, C DeMatos… - American journal of …, 2002 - atsjournals.org
Destruction of lung elastin is critical for development of emphysema associated with chronic
obstructive pulmonary disease (COPD). Lung macrophages release elastolytic enzymes, …
obstructive pulmonary disease (COPD). Lung macrophages release elastolytic enzymes, …
Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases
REK Russell, A Thorley, SV Culpitt… - … of Physiology-Lung …, 2002 - journals.physiology.org
Chronic obstructive pulmonary disease (COPD) is a common lung disease with cigarette
smoking as the major etiological factor, but only 15% of smokers develop COPD. Destruction of …
smoking as the major etiological factor, but only 15% of smokers develop COPD. Destruction of …
[HTML][HTML] Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
…, T Bengtsson, PJ Barnes, REK Russell… - The Lancet …, 2021 - thelancet.com
Background Multiple early reports of patients admitted to hospital with COVID-19 showed
that patients with chronic respiratory disease were significantly under-represented in these …
that patients with chronic respiratory disease were significantly under-represented in these …
[HTML][HTML] Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label …
Background A previous efficacy trial found benefit from inhaled budesonide for COVID-19 in
patients not admitted to hospital, but effectiveness in high-risk individuals is unknown. We …
patients not admitted to hospital, but effectiveness in high-risk individuals is unknown. We …
Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms
…, RHF Leung, K Ito, REK Russell… - … of Physiology-Lung …, 2004 - journals.physiology.org
Resveratrol (3,4′,5-trihydroxystilbene) is a polyphenolic stilbene found in the skins of red
fruits, including grapes, that may be responsible for some of the health benefits ascribed to …
fruits, including grapes, that may be responsible for some of the health benefits ascribed to …
Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease
…, P Shah, C De Matos, REK Russell… - American journal of …, 2003 - atsjournals.org
Chronic obstructive pulmonary disease (COPD) is characterized by inflammation of the
respiratory tract in which macrophages are the predominant inflammatory cell and for which the …
respiratory tract in which macrophages are the predominant inflammatory cell and for which the …
Treatment effects of low-dose theophylline combined with an inhaled corticosteroid in COPD
PA Ford, AL Durham, REK Russell, F Gordon… - Chest, 2010 - Elsevier
… Drs Durham, Russell, and Gordon have reported that no potential conflicts of interest exist
with any companies/organizations whose products or services may be discussed in this article…
with any companies/organizations whose products or services may be discussed in this article…
Eosinophils in COPD: just another biomarker?
Eosinophils are innate immune cells that, under certain conditions, can be recruited to the
lungs, where they have an incompletely understood role in health and disease. Eosinophils …
lungs, where they have an incompletely understood role in health and disease. Eosinophils …
[HTML][HTML] Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a …
Background Community-based clinical trials of the inhaled corticosteroid budesonide in
early COVID-19 have shown improved patient outcomes. We aimed to understand the …
early COVID-19 have shown improved patient outcomes. We aimed to understand the …
Enhanced monocyte migration to CXCR3 and CCR5 chemokines in COPD
…, KBR Belchamber, REK Russell… - European …, 2016 - Eur Respiratory Soc
Chronic obstructive pulmonary disease (COPD) patients exhibit chronic inflammation, both in
the lung parenchyma and the airways, which is characterised by an increased infiltration of …
the lung parenchyma and the airways, which is characterised by an increased infiltration of …